Profound haemodilution during normothermic cardiopulmonary bypass influences neither gastrointestinal permeability nor cytokine release in coronary artery bypass graft surgery

British Journal of Anaesthesia

Volumn 103, Issue 4, 2009, Pages 511-517

  Berger, K ^a   Sander, M ^a   Spies, C D ^a   Weymann, L ^a   Buhner S ^a   Lochs, H ^a   Wernecke, K D ^a   Von Heymann, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anaesthesia, general; Gastrointestinal tract, mucosal perfusion; Heart, cardiopulmonary bypass; Surgery, thoracic; Transfusion

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LACTULOSE; MANNITOL; SUCROSE; TUMOR NECROSIS FACTOR ALPHA; DIAGNOSTIC AGENT; DISACCHARIDE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOCRIT; HEMODILUTION; HUMAN; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; BIOSYNTHESIS; BODY TEMPERATURE; GASTROINTESTINAL TRACT; INTESTINE ABSORPTION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PERMEABILITY; PEROPERATIVE CARE; PILOT STUDY; PROSPECTIVE STUDY;

AGED; BODY TEMPERATURE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CYTOKINES; DISACCHARIDES; FEMALE; GASTROINTESTINAL TRACT; HEMATOCRIT; HEMODILUTION; HUMANS; INTESTINAL ABSORPTION; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PERMEABILITY; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 70350459095     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep201     Document Type: Article

References (29)

1. Neptune WB, Panico FG, Bougas JA. Clinical use of the pump-oxygenator without donor blood for priming or support during extracorporeal perfusion. Circulation 1959; 20: 745-746
2. Kaplan JA. Cardiac Anesthesia. Philadelphia: Saunders, 1993
3. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-1239
4. Koch CG, Li LA, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-1616
5. Defoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 2001; 71: 769-776
6. van Bommel J, Siegemund M, Henny CP, Trouwborst A, Ince C. Critical hematocrit in intestinal tissue oxygenation during severe normovolemic hemodilution. Anesthesiology 2001; 94: 152-160
7. Braun JP, Schroeder T, Buehner S, et al. Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand 2004; 48: 697-703
8. Jirik FR, Podor TJ, Hirano T, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human-endothelial cells. J Immunol 1989; 142: 144-147
9. Grover FL. The Society of Thoracic Surgeons National Database: current status and future directions. Ann Thorac Surg 1999; 68: 367-373
10. Jansen NJG, Vanoeveren W, Gu YJ, Vanvliet MH, Eijsman L, Wildevuur CRH. Endotoxin release and tumor-necrosis-factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744-748
11. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery-implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252
12. Sander M, von Heymann C, von Dossow V, et al. Increased interleukin-6 after cardiac surgery predicts infection. Anesth Analg 2006; 102: 1623-1629
13. von Heymann C, Sander M, Foer A, et al. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome-a randomized controlled study [ISRCTN35655335]. Crit Care 2006; 10: R58
14. Calafiore AM, Teodori G, Mezzetti A, et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59: 398-402
15. Braun JP, Buhner S, Kastrup M, et al. Barrier function of the gut and multiple organ dysfunction after cardiac surgery. J Int Med Res 2007; 35: 72-83
16. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose-a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104: 1619-1626
17. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437-1439
18. Brunner E, Langer F. Non-parametric Variance Analysis of Longitudinal Data. Munich: Oldenbourg, 1999
19. Thoren A, Nygren A, Houltz E, Ricksten SE. Cardiopulmonary bypass in humans-jejunal mucosal perfusion increases in parallel with well-maintained microvascular hematocrit. Acta Anaesthesiol Scand 2005; 49: 502-509
20. Kleen M, Habler O, Hutter J, et al. Effects of hemodilution on splanchnic perfusion and hepatorenal function. I. Splanchnic perfusion. Eur J Med Res 1997; 2: 413-418
21. Kleen M, Habler O, Hutter J, et al. Effects of hemodilution on gastric regional perfusion and intramucosal pH. Am J Physiol Heart Circ Physiol 1996; 40: H1849-55
22. Wei MX, Kuukasjarvi P, Laurikka J, et al. Relation of cytokines to vasodilation after coronary artery bypass grafting. World J Surg 2003; 27: 1093-1098 (Pubitemid 37259987)
23. Hansen PR. Myocardial reperfusion injury-experimental evidence and clinical relevance. Eur Heart J 1995; 16: 734-740
24. Wan S, Desmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112: 806-811
25. Naresh SN, Kapoor MC, Ramchandran TR, Kale SC. A comparative study of release of interleukin-6 and tumour necrosis factor during normothermic and hypothermic cardiopulmonary bypass. Ann Card Anaesth 2002; 5: 43-52
26. Bouter H, Schippers EF, Luelmo SAC, et al. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 2002; 30: 38-43
27. Defraigne JO, Pincemail J, Larbuisson R, Blaffart F, Limet R. Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration. Ann Thorac Surg 2000; 69: 1084-1091
28. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. Thorac Cardiovasc Surg 1999; 47: 111-118
29. Spies CD, Kern H, Schroder T, et al. Myocardial ischemia and cytokine response are associated with subsequent onset of infections after noncardiac surgery. Anesth Analg 2002; 95: 9-18